![Nicolas Leupin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nicolas Leupin
Nessuna posizione attualmente
Patrimonio netto: 2 M $ in data 31/07/2026
Profilo
Nicolas Leupin worked as Chief Medical Officer at argenx SE from 2016 to 2019 and at Molecular Partners AG from 2019 to 2023.
Also held the position of Chief Medical Officer at NovoCure Ltd. and was a Member of the Swiss Group for Clinical Research.
Education includes a doctorate from the University of Bern and an MBA from Jones International University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
NOVOCURE LTD. 0,09% | 06/04/2026 | 102.979 ( 0,09% ) | 2 M $ | 31/07/2026 |
Precedenti posizioni note di Nicolas Leupin
| Società | Posizione | Fine |
|---|---|---|
| MOLECULAR PARTNERS AG | Direttore Tecnico/Scientifico/R&S | 24/08/2023 |
| ARGENX SE | Direttore Tecnico/Scientifico/R&S | 01/07/2019 |
| NOVOCURE LIMITED | Direttore Tecnico/Scientifico/R&S | - |
Swiss Group for Clinical Research | Corporate Officer/Principal | - |
Formazione di Nicolas Leupin
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
28
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Jones International University
 Jones International University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Bern
 University of Bern Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Molecular Partners AG
 Molecular Partners AG BiotechnologyHealth Technology Engages in discovery, development and commercialization of biopharmaceutical products | Health Technology |
NovoCure Ltd.
 NovoCure Ltd. Medical SpecialtiesHealth Technology Operates as a commercial-stage oncology company | Health Technology |
argenx SE
 argenx SE BiotechnologyHealth Technology Develops therapies and medicines for the treatment of autoimmune diseases | Health Technology |
Swiss Group for Clinical Research |
